This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136: E359-386. 10.1002/ijc.2921025220842FerlayJSoerjomataramIDikshitREserSMathersCRebeloM.Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 20122015136E35938610.1002/ijc.2921025220842Open DOISearch in Google Scholar
Zadnik V, Primic Zakelj M, Lokar K, Jarm K, Ivanus U, Zagar T. Cancer burden in Slovenia with the time trends analysis. Radiol Oncol 2017; 51: 47-55. 10.1515/raon-2017-000828265232ZadnikVPrimic ZakeljMLokarKJarmKIvanusUZagarT.Cancer burden in Slovenia with the time trends analysis201751475510.1515/raon-2017-0008533017428265232Open DOISearch in Google Scholar
IARC/WHO. Helicobacter pylori eradication as a strategy for preventing gastric cancer. International Agency for Research on Cancer/World Health Organisation; 2014. [citated 2017 Avg 15]. Available at http://www.iarc.fr/en/publications/pdfs-online/wrk8/ or www.iarc.fr/en/publications/pdfs-online/wrk8/. ISBN 978-92-832-2454-9IARC/WHO. Helicobacter pylori eradication as a strategy for preventing gastric cancer2014[citated 2017 Avg 15]. Available athttp://www.iarc.fr/en/publications/pdfs-online/wrk8/www.iarc.fr/en/publications/pdfs-online/wrk8/ISBN 978-92-832-2454-9Search in Google Scholar
Malfertheiner P, Megraud F, O ’Morain CA, Gisbert JP, Kuipers EJ, Axon AT, et al. Management of Helicobacter pylori infection–the Maastricht V/Florence Consensus Report. Gut 2017; 66: 6-30. 10.1136/gutjnl-2012-30208427707777MalfertheinerPMegraudFO’MorainCAGisbertJPKuipersEJAxonATManagement of Helicobacter pylori infection–the Maastricht V/Florence Consensus Report20176663010.1136/gutjnl-2012-30208422491499Open DOISearch in Google Scholar
Nakajima S. Gastric cancer screening in Japan, now and tomorrow. Nihon Rinsho 2012; 70: 1686-93. 10.1007/s10120020000023198546NakajimaS.Gastric cancer screening in Japan, now and tomorrow20127016869310.1007/s10120020000012021853Open DOISearch in Google Scholar
Choi IJ. Screening and surveillance of gastric cancer. Korean J Gastroenterol 2007; 49: 15-22. 10.4166/kjg.2009.54.2.67ChoiIJ.Screening and surveillance of gastric cancer200749152210.4166/kjg.2009.54.2.6719696534Open DOISearch in Google Scholar
Dinis-Ribeiro M, Areia M, de Vries AC, Marcos-Pinto R, Monteiro-Soares M, O Connor A, et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy 2012; 44: 74-94. 10.1055/s-0031-1291491Dinis-RibeiroMAreiaMde VriesACMarcos-PintoRMonteiro-SoaresMO ConnorAManagement of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED)201244749410.1055/s-0031-1291491336750222198778Open DOISearch in Google Scholar
Tepeš B. Kavalar R. [Gastric cancer, screening possibilities and proposals for endoscopic and histologic follow-up of premalignant gastric lesions]. [Slovenian]. Zdrav Vestn 2010; 79: 366-74. https://doi.org/10.6016/290TepešB.KavalarR.[Gastric cancer, screening possibilities and proposals for endoscopic and histologic follow-up of premalignant gastric lesions]. [Slovenian]20107936674https://doi.org/10.6016/290Search in Google Scholar
Yuan Y. A survey and evaluation of population-based screening for gastric cancer. Cancer Biol Med 2013; 10: 72-80. 10.7497/j.issn.2095-3941.2013.02.00223882421YuanY.A survey and evaluation of population-based screening for gastric cancer201310728010.7497/j.issn.2095-3941.2013.02.002371919323882421Open DOISearch in Google Scholar
Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-9. 10.1056/NEJMoa00199911556297UemuraNOkamotoSYamamotoSMatsumuraNYamaguchiSYamakidoMHelicobacter pylori infection and the development of gastric cancer2001345784910.1056/NEJMoa00199911556297Open DOISearch in Google Scholar
Syrjänen K. A Panel of Serum Biomarkers (GastroPanel®) in Non-invasive diagnosis of atrophic gastritis. Systematic review and meta-analysis. Anticancer Res 2016; 36: 5133-44. 10.21873/anticanres.1108327798873SyrjänenK.A Panel of Serum Biomarkers (GastroPanel®) in Non-invasive diagnosis of atrophic gastritis. Systematic review and meta-analysis20163651334410.21873/anticanres.1108327798873Open DOISearch in Google Scholar
Matsushima M, Miki K, Ichinose M, Kakei N, Yahagi N, Suzuki T, et al. The clinical application of the serum pepsinogen I and II levels as a mass screening method for gastric cancer. In: Takahashi K, editor. Aspartic proteinases: advances in experimental medicine and biology. New York: Plenum Press; 1995. p. 139-43.MatsushimaMMikiKIchinoseMKakeiNYahagiNSuzukiTThe clinical application of the serum pepsinogen I and II levels as a mass screening method for gastric cancerTakahashiKNew YorkPlenum Press19951394310.1007/978-1-4615-1871-6_178540312Search in Google Scholar
Screening, early detection and treatment of cancer in China. Dong ZW, editor. Beijing: People’s Medical Publishing House; 2009.DongZWBeijingPeople’s Medical Publishing House2009Search in Google Scholar
Early detection and treatment of cancer committee. Technical solution on early detection and treatment of cancer in China. Beijing: People’s Medical Publishing House; 2011.Early detection and treatment of cancer committeeBeijingPeople’s Medical Publishing House2011Search in Google Scholar
Sipponen P. Biomarkers in clinical practice: a tool to find subjects at high risk for stomach cancer. A personal view. Adv Med Sci 2006; 51: 51-3.17357277SipponenP.Biomarkers in clinical practice: a tool to find subjects at high risk for stomach cancer. A personal view200651513Search in Google Scholar
Väänänen H, Vauhkonen M, Helske T, Kääriäinen I, Rasmussen M, Tunturi-Hihnala H, et al. Nonendoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study. Eur J Gastroenterol Hepatol 2003; 15: 885-91. 10.1097/01.meg.0000059169.46867.01VäänänenHVauhkonenMHelskeTKääriäinenIRasmussenMTunturi-HihnalaHNonendoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study2003158859110.1097/01.meg.0000059169.46867.01Open DOISearch in Google Scholar
Agréus L, Kuipers EJ, Kupcinskas L, Malfertheiner P, Di Mario F, Leja M, et al. Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers. Scand J Gastroenterol 2012; 47: 136-47. 10.3109/00365521.2011.64550122242613AgréusLKuipersEJKupcinskasLMalfertheinerPDi MarioFLejaMRationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers2012471364710.3109/00365521.2011.645501327913222242613Open DOISearch in Google Scholar
Dixon M, Genta R, Yardley J, Correa P. Classification and grading of gastritis: the updated Sydney System. Am J Surg Pathol 1996; 10: 1161-81.DixonMGentaRYardleyJCorreaP.Classification and grading of gastritis: the updated Sydney System19961011618110.1097/00000478-199610000-000018827022Search in Google Scholar
Rugge M, Meggio A, Pennelli G, Piscioli F, Giacomelli L, De Pretis G, et al. Gastritis staging in clinical practice: the OLGA staging system. Gut 2007; 56: 631-6. 10.1136/gut.2006.10666617142647RuggeMMeggioAPennelliGPiscioliFGiacomelliLDe PretisGGastritis staging in clinical practice: the OLGA staging system200756631610.1136/gut.2006.106666194214317142647Open DOISearch in Google Scholar
Capelle LG, de Vries AC, Haringsma J. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest Endosc 2010; 71: 1150-8. 10.1016/j.gie.2009.12.02920381801CapelleLGde VriesACHaringsmaJ.The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis2010711150810.1016/j.gie.2009.12.02920381801Open DOISearch in Google Scholar
Tepeš B, Štabuc B. Slovenian society for gastroenterology and hepatology guidelines on the management of Helicobacter pylori infection. [Slovenian]. Zdrav Vestn 2011; 80: 647-56. https://doi.org/10.6016/216TepešBŠtabucB.Slovenian society for gastroenterology and hepatology guidelines on the management of Helicobacter pylori infection. [Slovenian]20118064756https://doi.org/10.6016/216Search in Google Scholar
Syrjänen KJ, Sipponen P, Härkönen M, Peetsalu A and Korpela S. Accuracy of GastroPanel testing in detection of atrophic gastritis. Eur J Gastroenterol Hepatol 2015; 27: 102-4. 10.1097/MEG.0000000000000215SyrjänenKJSipponenPHärkönenMPeetsaluAKorpelaS.Accuracy of GastroPanel testing in detection of atrophic gastritis201527102410.1097/MEG.0000000000000215433758425426982Open DOISearch in Google Scholar
Hamashima C, Shibuya D, Yamazaki H, Inoue K, Fukao A, Saito H, et al. The Japanese guidelines for gastric cancer screening. Jpn J Clin Oncol 2008; 38: 259-67. 10.1093/jjco/hyn01718344316HamashimaCShibuyaDYamazakiHInoueKFukaoASaitoHThe Japanese guidelines for gastric cancer screening2008382596710.1093/jjco/hyn01718344316Open DOISearch in Google Scholar
Jung KW, Park S, Kong HJ, Won YJ, Boo YK, Shin HR, et al. Cancer statistics in Korea: incidence, mortality and survival in 2006-2007. J Korean Med Sci 2010; 25: 1113-21. 10.3346/jkms.2010.25.8.111320676319JungKWParkSKongHJWonYJBooYKShinHRCancer statistics in Korea: incidence, mortality and survival in 2006-200720102511132110.3346/jkms.2010.25.8.1113290877720676319Open DOISearch in Google Scholar
Miki K, Ichinose M, Kawamura N, Matsushima M, Ahmad HB, Kimura M, et al. The significance of low serum pepsinogen levels to detect stomach cancer associated with extensive chronic gastritis in Japanese subjects. Jpn J Cancer Res 1989; 80: 111-4.249824510.1111/j.1349-7006.1989.tb02276.xMikiKIchinoseMKawamuraNMatsushimaMAhmadHBKimuraMThe significance of low serum pepsinogen levels to detect stomach cancer associated with extensive chronic gastritis in Japanese subjects198980111459177072498245Search in Google Scholar
Zhang X, Xue L, Xing L, Wang J, Cui J, Mi J, et al. Low serum pepsinogen I and pepsinogen I/II ratio and Helicobacter pylori infection are associated with increased risk of gastric cancer: 14year follow up result in a rural Chinese community. Int J Cancer 2012; 130: 1614-9. 10.1002/ijc.26172ZhangXXueLXingLWangJCuiJMiJLow serum pepsinogen I and pepsinogen I/II ratio and Helicobacter pylori infection are associated with increased risk of gastric cancer: 14year follow up result in a rural Chinese community20121301614910.1002/ijc.2617221547904Open DOISearch in Google Scholar
Yuan Y. Population-based gastric cancer screening in Zhuanghe, Liaoning, from 1997 to 2011. Zhonghua Zhong Liu Za Zhi 2012; 34: 538-42.22967474YuanY.Population-based gastric cancer screening in Zhuanghe, Liaoning, from 1997 to 201120123453842Search in Google Scholar
Tepeš B, Štabuc B. Slovenian Association for Gastroenterology and hepatology recommendations for the management of patients infected with Helicobacter pylori. Zdrav Vestn 2017 (in press).TepešBŠtabucB.Slovenian Association for Gastroenterology and hepatology recommendations for the management of patients infected with Helicobacter pylori2017(in press)Search in Google Scholar
Sipponen P, Graham DY. Importance of atrophic gastritis in diagnostics and prevention of gastric cancer: application of plasma biomarkers. Scand J Gastroenterol 2007; 42: 2–10. 10.1080/0036552060086372017190755SipponenPGrahamDY.Importance of atrophic gastritis in diagnostics and prevention of gastric cancer: application of plasma biomarkers20074221010.1080/0036552060086372017190755Open DOISearch in Google Scholar
Roman LD, Lukyanchuk R, Sablin OA, Araslanova, EI, Eklund C, Hendolin P, et al. Prevalence of H. pyloriInfection and atrophic gastritis in a population-based screening with serum biomarker panel (GastroPanel®) in St. Petersburg. Anticancer Res 2016; 36: 4129-38.RomanLDLukyanchukRSablinOAAraslanovaEIEklundCHendolinPPrevalence of H. pyloriInfection and atrophic gastritis in a population-based screening with serum biomarker panel (GastroPanel®) in St. Petersburg201636412938Search in Google Scholar
Storskrubb T, Aro P, Ronkainen J, Sipponen P, Nyhlin H, Talley NJ, et al. Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: the Kalixanda study. Scand J Gastroenterol 2008; 43: 1448-55. 10.1080/00365520802273025StorskrubbTAroPRonkainenJSipponenPNyhlinHTalleyNJSerum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: the Kalixanda study20084314485510.1080/0036552080227302518663663Open DOISearch in Google Scholar
Sipponen P, Correa P. Delayed rise in incidence of gastric cancer in females results in unique sex ratio (M/F) pattern: etiologic hypothesis. Gastric Cancer 2002; 5: 213-9. 10.1007/s10120020003712491079SipponenPCorreaP.Delayed rise in incidence of gastric cancer in females results in unique sex ratio (M/F) pattern: etiologic hypothesis20025213910.1007/s10120020003712491079Open DOISearch in Google Scholar
Camargo MC, Goto Y, Zabaleta J, Morgan DR, Correa P, Rabkin CS. Sex hormones, hormonal interventions, and gastric cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2012; 21: 20-38. 10.1158/1055-9965.EPI-11-0834CamargoMCGotoYZabaletaJMorganDRCorreaPRabkinCS.Sex hormones, hormonal interventions, and gastric cancer risk: a meta-analysis201221203810.1158/1055-9965.EPI-11-0834331535522028402Open DOISearch in Google Scholar
Sipponen P, Kekki M, Haapakoski J, Ihamäki T, Siurala M. Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int J Cancer 1985; 35: 173-7.387173810.1002/ijc.2910350206SipponenPKekkikiTSiuralaM.Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data19853517373871738Search in Google Scholar
Roosendaal R, Kuipers EJ, Buitenwerf J, van Uffelen C, Meuwissen SG, van Kamp GJ, Vandenbroucke-Grauls CM. Helicobacter pylori and the birth cohort effect: evidence of a continuous decrease of infection rates in childhood. Am J Gastroenterol 1997; 92: 1480-2.9317067RoosendaalRKuipersEJBuitenwerfJvan UffelenCMeuwissenSGvan KampGJVandenbroucke-GraulsCM.Helicobacter pylori and the birth cohort effect: evidence of a continuous decrease of infection rates in childhood19979214802Search in Google Scholar
Väänänen H, Vauhkonen M, Helske T, Kääriäinen I, Rasmussen M, Tunturi-Hihnala H, et al. Nonendoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study. Eur J Gastroenterol Hepatol 2003; 15: 885-91. 10.1097/01.meg.0000059169.46867.01VäänänenHVauhkonenMHelskeTKääriäinenIRasmussenMTunturi-HihnalaHNonendoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study2003158859110.1097/01.meg.0000059169.46867.01Open DOISearch in Google Scholar
Gubina M, Tepeš B, Vidmar G, Logar J, Wraber B, Poljanec J, Bricelj I, et al. The prevalence of Helicobacter pylori infection in Slovenia in 2005. ZdravVestn 2006; 75: 169-73.GubinaMTepešBVidmarGLogarJWraberBPoljanecJBriceljIThe prevalence of Helicobacter pylori infection in Slovenia in 200520067516973Search in Google Scholar
Benberin V, Bektayeva R, Karabayeva R, Lebedev A, Akemeyeva K, Paloheimo L, et al. Prevalence of H. pylori infection and atrophic gastritis among asymptomatic and dyspeptic adults in Kazakhstan. A Hospital-Based screening with a panel of serum biomarkers. Anticancer Res 2013; 33: 4595-602.24123036BenberinVBektayevaRKarabayevaRLebedevAAkemeyevaKPaloheimoLPrevalence of H. pylori infection and atrophic gastritis among asymptomatic and dyspeptic adults in Kazakhstan. A Hospital-Based screening with a panel of serum biomarkers2013334595602Search in Google Scholar